Previous close | 37.99 |
Open | 35.91 |
Bid | 35.75 x 40000 |
Ask | 39.35 x 40000 |
Day's range | 35.91 - 35.91 |
52-week range | 23.45 - 40.35 |
Volume | |
Avg. volume | 10,548 |
Market cap | 70.276B |
Beta (5Y monthly) | 0.24 |
PE ratio (TTM) | 52.81 |
EPS (TTM) | 0.68 |
Earnings date | 31 Jul 2024 |
Forward dividend & yield | 0.39 (1.08%) |
Ex-dividend date | 27 Sept 2024 |
1y target est | 38.04 |
TOKYO & BASKING RIDGE, N.J., June 28, 2024--A dispute between Daiichi Sankyo Co., Ltd. (TSE: 4568) and Seagen Inc. is now concluded and Seagen has paid Daiichi Sankyo approximately U.S. $47 million in connection with attorneys’ fees and costs plus interest awarded by the arbitrator of the party’s dispute.
Merck stock tumbled under its 50-day moving average Thursday after the FDA rejected its Daiichi Sankyo-partnered cancer drug.
The FDA's CRL to Merck (MRK) and its partner Daiichi Sankyo for the patritumab deruxtecan BLA is based on observations made on inspection of a third-party manufacturing facility.